HOLLANDER DAVID (CMO & Global Therapeutics Lead) sold 3.6% of their position (3.91K shares) of REVANCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/19/2024ACC: 0001479290-24-000130
Officer· CMO & Global Therapeutics Lead
Since Feb 2024
-3.91K
Net shares
Net seller
$16.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.91K
Price / share
$4.17
Trade value
$16.30K
% of position
3.6%
11/18/2024
108.85K→104.94K
Total
Net shares
−3.91K
Net value
-$16.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2024 | S · Sale | −3.91K | $4.17 | $16.30K | 3.6% | 108.85K | 104.94K |
| Total | −3.91K | -$16.30K | ||||||
Derivative Transactions0
No derivative transactions reported